Visceral heterotaxy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:450OMIM:619702Q89.3
Who is this for?
Show terms as
2Active trials4Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Visceral heterotaxy, also known as heterotaxy syndrome or situs ambiguus, is a rare condition where the internal organs of the chest and abdomen are not arranged in their normal positions. In a typical body, the heart sits slightly to the left, the liver is on the right, and the stomach and spleen are on the left. In heterotaxy, this normal left-right arrangement is disrupted, and organs may be mirrored, duplicated, absent, or placed in unusual positions. The word 'heterotaxy' comes from Greek words meaning 'different arrangement.' The heart is almost always affected, and most people with heterotaxy have complex congenital heart defects that require surgery. There are two main types: asplenia syndrome (also called right isomerism), where the spleen is absent and both sides of the body look like the right side; and polysplenia syndrome (also called left isomerism), where there are multiple small spleens and both sides resemble the left side. Other organs like the lungs, liver, intestines, and bile ducts can also be abnormally positioned or formed. Symptoms depend on which organs are affected and how severely. Heart problems are the most serious concern and can cause breathing difficulties, bluish skin color, and poor feeding in newborns. Digestive problems, repeated infections (especially without a working spleen), and abnormal lung structure are also common. Treatment focuses on correcting heart defects through surgery, preventing infections, and managing complications from other affected organs. Care requires a team of specialists working together throughout a person's life.

Also known as:

Key symptoms:

Complex heart defects present from birthBluish or purplish skin color (cyanosis) due to low oxygen levelsDifficulty breathing, especially in newbornsPoor feeding and slow weight gain in infantsOrgans in unusual positions (heart, liver, stomach, spleen)Absent spleen, leading to increased risk of serious infectionsMultiple small spleens that may not work properlyAbnormal lung structure or lung lobesIntestinal malrotation, which can cause bowel blockagesJaundice or liver and bile duct problemsRepeated or severe bacterial infectionsAbnormal heart rhythm (arrhythmia)Fatigue and low energy due to heart or lung problems

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

4 events
Jan 2026Conduction System Pacing and AV Junction Ablation in Heart Failure With Atrial Fibrillation (SYNC AF-HTx)

Yonsei University — NA

TrialNOT YET RECRUITING
Jul 2025METABolic Deterioration in HTX Determines Outcomes

Heinrich-Heine University, Duesseldorf

TrialRECRUITING
Apr 2021COMPASSION S3 Post-Approval Study

Edwards Lifesciences

TrialACTIVE NOT RECRUITING
Jul 2016COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

Edwards Lifesciences — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Visceral heterotaxy.

2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

2 recruitingView all trials with filters →
N/A1 trial
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
N/A
Actively Recruiting
PI: D. Scott Lim, MD (University of Virginia Medical Center) · Sites: Little Rock, Arkansas; Los Angeles, California +23 more
Other1 trial
COMPASSION S3 Post-Approval Study
Active
· Sites: Birmingham, Alabama; Los Angeles, California +17 more

Specialists

4 foundView all specialists →
LM
Lindsay Ryerson, MD
ANN ARBOR, MI
Specialist
PI on 1 active trial1 Visceral heterotaxy publication
SP
Stephanie M. Ware, MD, PhD
Specialist
PI on 1 active trial
TB
Terence Prendiville, MB BCh BAO
Specialist
PI on 1 active trial3 Visceral heterotaxy publications
AP
Alan L. Ho, MD, PhD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Visceral heterotaxy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Visceral heterotaxyForum →

No community posts yet. Be the first to share your experience with Visceral heterotaxy.

Start the conversation →

Latest news about Visceral heterotaxy

Disease timeline:

New recruiting trial: METABolic Deterioration in HTX Determines Outcomes

A new clinical trial is recruiting patients for Visceral heterotaxy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific organs are affected in my child's case, and how does that change the treatment plan?,Does my child have a working spleen, and if not, what infection prevention steps do we need to follow every day?,What heart surgeries will my child need, and what is the expected timeline?,Should our family have genetic testing, and what does it mean for future pregnancies?,What signs of complications should prompt an emergency room visit?,What are the long-term health risks as my child grows into adulthood, and when should we transition to an adult specialist?,Are there clinical trials or research studies that my child might be eligible for?

Common questions about Visceral heterotaxy

What is Visceral heterotaxy?

Visceral heterotaxy, also known as heterotaxy syndrome or situs ambiguus, is a rare condition where the internal organs of the chest and abdomen are not arranged in their normal positions. In a typical body, the heart sits slightly to the left, the liver is on the right, and the stomach and spleen are on the left. In heterotaxy, this normal left-right arrangement is disrupted, and organs may be mirrored, duplicated, absent, or placed in unusual positions. The word 'heterotaxy' comes from Greek words meaning 'different arrangement.' The heart is almost always affected, and most people with het

How is Visceral heterotaxy inherited?

Visceral heterotaxy follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Visceral heterotaxy typically begin?

Typical onset of Visceral heterotaxy is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Visceral heterotaxy?

Yes — 2 recruiting clinical trials are currently listed for Visceral heterotaxy on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Visceral heterotaxy?

4 specialists and care centers treating Visceral heterotaxy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.